J&J to pay $181 million, ending suits
Aug 31, 2012 | Posted by: roboblogger | Full story: Journal Gazette
Johnson & Johnson will pay $181 million to resolve claims by 36 states that it improperly marketed and advertised the antipsychotic drugs Risperdal and Invega.
I hope they can do this on people affected of their vaginal meshes. See http://www.vaginalmeshlawsuit.com/vaginal-mes...
I think this is good news to all people whose lives are changed since they were implanted with DePuy’s hip replacement devices. And one thing though, I hope that DePuy will find a better way on how to improve their products’ safety so that patients may no longer be harmed in the future. For more information, you may refer at http://www.depuypinnaclelawsuit.com/hip-repla...
|US clears Johnson & Johnson hepatitis C drug||Nov '13||WARNING FDA APPROVED||1|
|DePuy ASR Hip Lawsuit Update: Federal ASR Hip L... (Jul '13)||Jul '13||Jimmy||1|
|DePuy ASR Hip Recall: Status Conference Held in... (Jan '13)||Jul '13||Steve Austin||6|
|J&J to stop selling metal-on-metal hip replacem... (May '13)||Jul '13||Susan||2|
|New Market Report: DePuy Medical Device Company... (Jun '12)||Jul '13||Ray Lin||6|
|Lawsuits filed over recalled hip joints (Jul '11)||Jul '13||Bryan||10|
|Trial under way in LA hip joint replacement suit (Jan '13)||Jul '13||Steve Austin||6|